USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
AI CURE TECHNOLOGIES, LLC
Address:
AI CURE TECHNOLOGIES, LLC
New York, NY 10010-
Phone:
N/A
URL:
N/A
EIN:
127083230
DUNS:
831784215
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $638,295.00 3
SBIR Phase II $2,781,604.00 2

Award List:

Gesture Based Medication Adherence Confirmation for Clinical Trials

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$273,165.00
Agency:
HHS
Principal Investigator:
Adam Hanina – 646-784-2304
Abstract:
DESCRIPTION (provided by applicant): Ai Cure Technologies LLC, was established in 2009 to develop webcam software solutions for mobile devices and other computing platforms that automate and reduce the cost of monitoring patient behavior and medication adherence. Poor medication adherence is one of… More

Fractal Identification System for Medication

Award Year / Program / Phase:
2012 / SBIR / Phase I
Award Amount:
$227,209.00
Agency:
HHS
Principal Investigator:
Adam Hanina – 646-784-2304
Abstract:
DESCRIPTION (provided by applicant): Ai Cure Technologies LLC, was established in 2009 to develop computer vision solutions to ensure safer medication usage. This SBIR Phase I will allow Ai Cure Technologies to prove feasibility of an innovative identification and anti-counterfei labeling solution… More

OTHER FUNCTIONS: SBIR PHASE I, MED. ADHERENCE IN HIGHER RISK POPULATIONS, N43DA-12-2227, BASE AWARD.

Award Year / Program / Phase:
2012 / SBIR / Phase I
Award Amount:
$137,921.00
Agency:
HHS
Principal Investigator:
Adam Hanina – 646-723-1260
Abstract:
AI Cure Technologies seeks to develop and test the effectiveness and usability of AiView-HR, an automated, population-based medication adherence monitoring system for high-risk, substance abuse populations. AiView-HR will be a significant extension of Ai Cure Technologies' flagship… More

Automating Directly Observed Therapy as a Platform Technology

Award Year / Program / Phase:
2013 / SBIR / Phase II
Award Amount:
$1,784,113.00
Agency:
HHS
Principal Investigator:
Adam Hanina – 646-784-2304
Abstract:
DESCRIPTION (provided by applicant): Introduction: Ai Cure Technologies LLC was established in 2009 to develop automated medication adherence monitoring solutions using computer vision technology. This SBIR Phase II will allow Ai Cure Technologies to testthe accuracy and validity of its flagship… More

Funding of Phase II SBIR Contract. N44 DA-12-2227

Award Year / Program / Phase:
2013 / SBIR / Phase II
Award Amount:
$997,491.00
Agency:
HHS
Principal Investigator:
Adam Hanina – 646-723-1260
Abstract:
Under this Small Business Innovation Research (SBIR) Phase II project, Automating Directly Observed Therapy as a Platform Technology, under Research Topic 139, the Contractor shall provide and evaluate the effectiveness and accuracy of a system for monitoring medication adherence in a treatment… More